| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/27/2001 | CA2403788A1 Receptor-binding compounds and methods for identifying them |
| 09/27/2001 | CA2403784A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2402643A1 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 09/27/2001 | CA2391316A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1136068A2 Powder containing physiologically active peptide |
| 09/26/2001 | EP1135405A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION |
| 09/26/2001 | EP1135350A1 Carriers for combinatorial compound libraries |
| 09/26/2001 | EP1135155A1 Methods of inhibiting ectopic calcification |
| 09/26/2001 | EP0902834A4 Stable avidin composition and methods using same |
| 09/26/2001 | EP0859792B1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 09/26/2001 | EP0842142B1 Process for producing alpha-(n,n dialkyl)-amino carboxylic acid amides |
| 09/26/2001 | EP0809653B1 Helicobacter pylori antigen |
| 09/26/2001 | EP0733205B1 Method for removal of binding proteins from ligands |
| 09/26/2001 | CN1314490A Method for producing yeast expressed human tissue plasminogen activator and its activity detection |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/25/2001 | US6294174 Peptides immunologically related to known viral protein |
| 09/25/2001 | CA2227318C Process for protein refolding by means of buffer exchange using a continuous stationary phase capable of separating proteins from salt |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/25/2001 | CA1341296C 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use |
| 09/20/2001 | WO2001069415A2 Methods, software, and apparati for designing, ordering, pricing, tracking and directing production of custom biologicals |
| 09/20/2001 | WO2001068861A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 09/20/2001 | WO2001068676A2 Lhrh-antagonists, production and use thereof as medicament |
| 09/20/2001 | WO2001068672A1 Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates |
| 09/20/2001 | WO2001068671A1 Method of making protein arrays |
| 09/20/2001 | WO2001068664A2 Mass labels |
| 09/20/2001 | WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/20/2001 | WO2001068598A2 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form |
| 09/20/2001 | WO2001068565A2 Chemoselective ligation by use of a phosphine |
| 09/20/2001 | WO2001014407A3 Refolding of membrane proteins, using two different detergents |
| 09/20/2001 | WO2000012587A8 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 09/20/2001 | CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/20/2001 | CA2402584A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form |
| 09/20/2001 | CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2391063A1 Protein hydrolyzate, manufacuring method therefor, and foods and drinks containing the protein hydrolyzate |
| 09/19/2001 | EP1133698A1 Prion protein standard and method of making same |
| 09/19/2001 | EP1133317A1 Transport system conjugate |
| 09/19/2001 | EP0889901B1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/19/2001 | EP0700300B1 Purification of plasma proteins |
| 09/19/2001 | EP0640099B1 Peptides having tachykinin antagonist activity |
| 09/19/2001 | CN1313896A Method for producing a peptide with a PI above 8 or below 5 |
| 09/19/2001 | CN1313866A Method for chromatographically purifying insulins |
| 09/19/2001 | CN1313771A Method for detection of i(legionella) bacteria employing purified antigen-specific antibodies |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/19/2001 | CN1313290A Hydrolytic active substance of brain protein, its preparing process and its activity and sequence |
| 09/19/2001 | CN1071337C Purification process for hirudin using affinity chromatography |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291646 A receptor polypeptide having a ligand-binding domain joined to an immunoglobulin constant region; therapy for atherosclerosis, autocrine tumors, fibroplasia and keloid formation |
| 09/18/2001 | US6291582 Polymer-protein composites and methods for their preparation and use |
| 09/18/2001 | US6291424 Nitrosated and nitrosylated heme proteins |
| 09/18/2001 | US6291212 Nucleotide sequences coding polypeptide for the detection and purification of human platelet derived growth factor or isoforms |
| 09/18/2001 | US6291201 Fluorescence energy transfer substrates |
| 09/18/2001 | US6291192 Method for identifying conditions that facilitate recombinant protein folding |
| 09/18/2001 | US6291191 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
| 09/18/2001 | US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis |
| 09/18/2001 | US6290970 Transferrin receptor protein of Moraxella |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | US6290915 Apparatus for combinatorial chemistry for the synthesis of potential drug candidate molecules. |
| 09/18/2001 | CA2036197C Modified hil-6 |
| 09/13/2001 | WO2001067299A1 Method of anticipating interaction between proteins |
| 09/13/2001 | WO2001066554A2 Solid phase synthesis method and reagent |
| 09/13/2001 | WO1997041130A3 Sulfurization of phosphorus-containing compounds |
| 09/13/2001 | US20010021388 Cyclization of a triether with a diamine compound |
| 09/13/2001 | CA2402606A1 Method for predicting protein-protein interactions |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132469A2 Methods for separating nucleic acids from Protein-nucleic acids complexes |
| 09/12/2001 | EP1132394A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 09/12/2001 | EP1131448A2 Producing antimicrobial cationic peptides as fusion proteins |
| 09/12/2001 | EP1131339A1 Method for continuously isolating active proteins |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP1047445A4 Modified enzymes and their use for peptide synthesis |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312818A Chemical synthesis of exochelins |
| 09/12/2001 | CN1312295A Flocculation charification-ultrafiltration concentration process of producing composite immunoreactive protein |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288037 C-terminally modified pentapeptides containing valine and aspartic acid |
| 09/11/2001 | US6288030 Lyophilized formulation of stem cell factor (scf) mixed with histidine as stabilizing buffer |
| 09/11/2001 | US6288029 Template assembled synthetic peptide effective to treat respiratory system disorders |
| 09/11/2001 | US6287794 Peptide having antithrombotic effect through reversible inhibition of blood coagulation factor; antiinflammatory agents; treatment of cardiovascular disorders |
| 09/11/2001 | US6287787 Dimeric oligopeptide mixture sets |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287517 Active electrodes especially adapted for electrophoretic transport of nucleic acids, their hybridization and analysis |
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/11/2001 | CA2023194C Peptides having bradykinin antagonist action |
| 09/07/2001 | WO2001064748A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 09/07/2001 | WO2001064711A1 Method of separating and purifying protein |
| 09/07/2001 | WO2001064237A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 09/07/2001 | WO2001055449A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055440A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001016160A3 Purification and analysis of cyclic peptide libraries, and compositions thereof |
| 09/07/2001 | WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 09/07/2001 | WO2001010886A3 Automated protein purification in the multiwell format by vacuum filtration |
| 09/07/2001 | WO2000071571A3 Fap-activated anti-tumor compounds |
| 09/07/2001 | CA2402417A1 Method of separating and purifying protein |
| 09/07/2001 | CA2399847A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 09/05/2001 | EP1130399A2 Method and product for the sequence determination of peptides using a mass spectrometer |
| 09/05/2001 | EP1129354A1 A method for determining a mimotope sequence |